Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023 15:48 ET
|
Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Appoints William J. Kullback Chief Financial Officer
August 29, 2023 16:05 ET
|
Telesis Bio
SAN DIEGO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial...
Telesis Bio Reports Second Quarter 2023 Financial Results
August 10, 2023 16:05 ET
|
Telesis Bio
SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the second...
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
August 03, 2023 17:00 ET
|
Telesis Bio
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its second quarter...
Telesis Bio to Present at Jefferies Healthcare Conference 2023
June 08, 2023 09:05 ET
|
Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
June 06, 2023 03:00 ET
|
Telesis Bio
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
June 05, 2023 17:30 ET
|
Telesis Bio
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced...
Telesis Bio Secures Financing of $28.0 Million
May 31, 2023 17:29 ET
|
Telesis Bio
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN...
Telesis Bio to Present at SynBioBeta 2023
May 23, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...